Presystemic 24-hydroxylation of oral 25-hydroxyvitamin D3 in rats

J Bone Miner Res. 1990 Nov;5(11):1177-82. doi: 10.1002/jbmr.5650051113.

Abstract

The metabolism of 25-hydroxyvitamin D3 (25-OHD3) was compared following its intracardial or gastric administration. The rats were deprived of calcium and vitamin D. A mixture of radiolabeled (0.3 microCi) and stable (2 micrograms) 25-OHD3 was given as a single dose. After 24 h the rats given the dose by gastric tube had significantly lower serum concentrations of 25-OHD3 and 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] than those injected intracardially. In contrast, serum 24,25-dihydroxyvitamin D3 [24,25-(OH)2D3] was much higher in the rats given the 25-OHD3 dose by gastric tube (6.2 nmol/liter +/- 1.3 SD, n = 7) compared to the intracardial group (0.9 nmol/liter +/- 0.5, p less than 0.001). The preceding results were based on specific radioactivity of metabolites. The same findings were obtained by reanalyzing the samples using conventional competitive binding assays for 25-OHD3, 1,25-(OH)2D3, and 24,25-(OH)2D3. The results show that orally administered 25-OHD3 is partly metabolized to 24,25-(OH)2D3 presystemically.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 24,25-Dihydroxyvitamin D 3 / blood
  • Administration, Oral
  • Animals
  • Calcifediol / administration & dosage
  • Calcifediol / metabolism*
  • Heart
  • Hydroxylation
  • Injections
  • Intestinal Mucosa / metabolism
  • Male
  • Rats
  • Rats, Inbred Strains

Substances

  • 24,25-Dihydroxyvitamin D 3
  • Calcifediol